BlackRock Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
BFA
CIP
BIT
BlackRock Group's IART Position: Q4 2016 in Review
BlackRock Group increased its Integra LifeSciences (IART) stake by 52% in Q4 2016, buying an estimated $1.71M and bringing the position to 122,860 shares worth $5.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1166.
BlackRock Group first reported a position in IART in Q2 2013 and has held it in 15 quarters since. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.
- BlackRock Group held 122,860 shares of Integra LifeSciences worth $5.27M as of Q4 2016.
- BlackRock Group bought 42,152 Integra LifeSciences shares in Q4 2016, an estimated $1.71M.
- Integra LifeSciences made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1166 holding.
- BlackRock Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 15 quarters since.
- 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.